+1 347 708 0418
Report Summary
Immuno-oncology Drugs-Global Market Status & Trend Report 2015-2026 Top 20 Countries Data offers a comprehensive analysis on Immuno-oncology Drugs industry, standing on the readers perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Immuno-oncology Drugs 2015-2019, and development forecast 2020-2026
Main manufacturers/suppliers of Immuno-oncology Drugs worldwide and market share by regions, with company and product introduction, position in the Immuno-oncology Drugs market
Market status and development trend of Immuno-oncology Drugs by types and applications
Cost and profit status of Immuno-oncology Drugs, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Immuno-oncology Drugs market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Immuno-oncology Drugs industry.
The report segments the global Immuno-oncology Drugs market as:
Global Immuno-oncology Drugs Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2015-2026):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Immuno-oncology Drugs Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2015-2026):
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Oncolytic Virus
Others
Global Immuno-oncology Drugs Market: Application Segment Analysis (Consumption Volume and Market Share 2015-2026; Downstream Customers and Market Analysis)
Hospitals
Clinics
Ambulatory Surgical Centers
Global Immuno-oncology Drugs Market: Manufacturers Segment Analysis (Company and Product introduction, Immuno-oncology Drugs Sales Volume, Revenue, Price and Gross Margin):
Amgen, Inc
Johnson & Johnson
Celgene Corporation
AstraZeneca, Plc
Hoffmann-La Roche AG
Bristol-Myers Squibb
AbbVie, Inc.
Merck & Co.
Eli Lilly and Company
Novartis International AG
Prometheus Therapeutics & Diagnostics
Bavarian Nordic
Pfizer Inc.
ImmunoCellular Therapeutics
Aduro BioTech
Gilead Sciences Inc.
Sanofi S.A.
Celldex Therapeutics
Galena Biopharma
EMD Serono, Inc.
Bio-Rad Laboratories, Inc.
Incyte
Lonza Group
Enzo Biochem, Inc.
Spring Bank Pharmaceuticals, Inc.
Agenus Inc.
Ferring Pharmaceuticals
Dendreon Corporation
Avantor, Inc.
Agilent Technologies Inc
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table of Contents
Chapter 1 Overview of Immuno-oncology Drugs
1.1 Definition of Immuno-oncology Drugs in This Report
1.2 Commercial Types of Immuno-oncology Drugs
1.2.1 Immune Checkpoint Inhibitors
1.2.2 Immune System Modulators
1.2.3 Cancer Vaccines
1.2.4 Oncolytic Virus
1.2.5 Others
1.3 Downstream Application of Immuno-oncology Drugs
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Ambulatory Surgical Centers
1.4 Development History of Immuno-oncology Drugs
1.5 Market Status and Trend of Immuno-oncology Drugs 2015-2026
1.5.1 Global Immuno-oncology Drugs Market Status and Trend 2015-2026
1.5.2 Regional Immuno-oncology Drugs Market Status and Trend 2015-2026
Chapter 2 Global Market Status and Forecast by Regions
2.1 Market Development of Immuno-oncology Drugs 2015-2019
2.2 Sales Market of Immuno-oncology Drugs by Regions
2.2.1 Sales Volume of Immuno-oncology Drugs by Regions
2.2.2 Sales Value of Immuno-oncology Drugs by Regions
2.3 Production Market of Immuno-oncology Drugs by Regions
2.4 Global Market Forecast of Immuno-oncology Drugs 2020-2026
2.4.1 Global Market Forecast of Immuno-oncology Drugs 2020-2026
2.4.2 Market Forecast of Immuno-oncology Drugs by Regions 2020-2026
Chapter 3 Global Market Status and Forecast by Types
3.1 Sales Volume of Immuno-oncology Drugs by Types
3.2 Sales Value of Immuno-oncology Drugs by Types
3.3 Market Forecast of Immuno-oncology Drugs by Types
Chapter 4 Global Market Status and Forecast by Downstream Industry
4.1 Global Sales Volume of Immuno-oncology Drugs by Downstream Industry
4.2 Global Market Forecast of Immuno-oncology Drugs by Downstream Industry
Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry
5.1 North America Immuno-oncology Drugs Market Status by Countries
5.1.1 North America Immuno-oncology Drugs Sales by Countries (2015-2019)
5.1.2 North America Immuno-oncology Drugs Revenue by Countries (2015-2019)
5.1.3 United States Immuno-oncology Drugs Market Status (2015-2019)
5.1.4 Canada Immuno-oncology Drugs Market Status (2015-2019)
5.1.5 Mexico Immuno-oncology Drugs Market Status (2015-2019)
5.2 North America Immuno-oncology Drugs Market Status by Manufacturers
5.3 North America Immuno-oncology Drugs Market Status by Type (2015-2019)
5.3.1 North America Immuno-oncology Drugs Sales by Type (2015-2019)
5.3.2 North America Immuno-oncology Drugs Revenue by Type (2015-2019)
5.4 North America Immuno-oncology Drugs Market Status by Downstream Industry (2015-2019)
Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry
6.1 Europe Immuno-oncology Drugs Market Status by Countries
6.1.1 Europe Immuno-oncology Drugs Sales by Countries (2015-2019)
6.1.2 Europe Immuno-oncology Drugs Revenue by Countries (2015-2019)
6.1.3 Germany Immuno-oncology Drugs Market Status (2015-2019)
6.1.4 UK Immuno-oncology Drugs Market Status (2015-2019)
6.1.5 France Immuno-oncology Drugs Market Status (2015-2019)
6.1.6 Italy Immuno-oncology Drugs Market Status (2015-2019)
6.1.7 Russia Immuno-oncology Drugs Market Status (2015-2019)
6.1.8 Spain Immuno-oncology Drugs Market Status (2015-2019)
6.1.9 Benelux Immuno-oncology Drugs Market Status (2015-2019)
6.2 Europe Immuno-oncology Drugs Market Status by Manufacturers
6.3 Europe Immuno-oncology Drugs Market Status by Type (2015-2019)
6.3.1 Europe Immuno-oncology Drugs Sales by Type (2015-2019)
6.3.2 Europe Immuno-oncology Drugs Revenue by Type (2015-2019)
6.4 Europe Immuno-oncology Drugs Market Status by Downstream Industry (2015-2019)
Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry
7.1 Asia Pacific Immuno-oncology Drugs Market Status by Countries
7.1.1 Asia Pacific Immuno-oncology Drugs Sales by Countries (2015-2019)
7.1.2 Asia Pacific Immuno-oncology Drugs Revenue by Countries (2015-2019)
7.1.3 China Immuno-oncology Drugs Market Status (2015-2019)
7.1.4 Japan Immuno-oncology Drugs Market Status (2015-2019)
7.1.5 India Immuno-oncology Drugs Market Status (2015-2019)
7.1.6 Southeast Asia Immuno-oncology Drugs Market Status (2015-2019)
7.1.7 Australia Immuno-oncology Drugs Market Status (2015-2019)
7.2 Asia Pacific Immuno-oncology Drugs Market Status by Manufacturers
7.3 Asia Pacific Immuno-oncology Drugs Market Status by Type (2015-2019)
7.3.1 Asia Pacific Immuno-oncology Drugs Sales by Type (2015-2019)
7.3.2 Asia Pacific Immuno-oncology Drugs Revenue by Type (2015-2019)
7.4 Asia Pacific Immuno-oncology Drugs Market Status by Downstream Industry (2015-2019)
Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry
8.1 Latin America Immuno-oncology Drugs Market Status by Countries
8.1.1 Latin America Immuno-oncology Drugs Sales by Countries (2015-2019)
8.1.2 Latin America Immuno-oncology Drugs Revenue by Countries (2015-2019)
8.1.3 Brazil Immuno-oncology Drugs Market Status (2015-2019)
8.1.4 Argentina Immuno-oncology Drugs Market Status (2015-2019)
8.1.5 Colombia Immuno-oncology Drugs Market Status (2015-2019)
8.2 Latin America Immuno-oncology Drugs Market Status by Manufacturers
8.3 Latin America Immuno-oncology Drugs Market Status by Type (2015-2019)
8.3.1 Latin America Immuno-oncology Drugs Sales by Type (2015-2019)
8.3.2 Latin America Immuno-oncology Drugs Revenue by Type (2015-2019)
8.4 Latin America Immuno-oncology Drugs Market Status by Downstream Industry (2015-2019)
Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry
9.1 Middle East and Africa Immuno-oncology Drugs Market Status by Countries
9.1.1 Middle East and Africa Immuno-oncology Drugs Sales by Countries (2015-2019)
9.1.2 Middle East and Africa Immuno-oncology Drugs Revenue by Countries (2015-2019)
9.1.3 Middle East Immuno-oncology Drugs Market Status (2015-2019)
9.1.4 Africa Immuno-oncology Drugs Market Status (2015-2019)
9.2 Middle East and Africa Immuno-oncology Drugs Market Status by Manufacturers
9.3 Middle East and Africa Immuno-oncology Drugs Market Status by Type (2015-2019)
9.3.1 Middle East and Africa Immuno-oncology Drugs Sales by Type (2015-2019)
9.3.2 Middle East and Africa Immuno-oncology Drugs Revenue by Type (2015-2019)
9.4 Middle East and Africa Immuno-oncology Drugs Market Status by Downstream Industry (2015-2019)
Chapter 10 Market Driving Factor Analysis of Immuno-oncology Drugs
10.1 Global Economy Situation and Trend Overview
10.2 Immuno-oncology Drugs Downstream Industry Situation and Trend Overview
Chapter 11 Immuno-oncology Drugs Market Competition Status by Major Manufacturers
11.1 Production Volume of Immuno-oncology Drugs by Major Manufacturers
11.2 Production Value of Immuno-oncology Drugs by Major Manufacturers
11.3 Basic Information of Immuno-oncology Drugs by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Immuno-oncology Drugs Major Manufacturer
11.3.2 Employees and Revenue Level of Immuno-oncology Drugs Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
Chapter 12 Immuno-oncology Drugs Major Manufacturers Introduction and Market Data
12.1 Amgen, Inc
12.1.1 Company profile
12.1.2 Representative Immuno-oncology Drugs Product
12.1.3 Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Amgen, Inc
12.2 Johnson & Johnson
12.2.1 Company profile
12.2.2 Representative Immuno-oncology Drugs Product
12.2.3 Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Johnson & Johnson
12.3 Celgene Corporation
12.3.1 Company profile
12.3.2 Representative Immuno-oncology Drugs Product
12.3.3 Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Celgene Corporation
12.4 AstraZeneca, Plc
12.4.1 Company profile
12.4.2 Representative Immuno-oncology Drugs Product
12.4.3 Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of AstraZeneca, Plc
12.5 Hoffmann-La Roche AG
12.5.1 Company profile
12.5.2 Representative Immuno-oncology Drugs Product
12.5.3 Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Hoffmann-La Roche AG
12.6 Bristol-Myers Squibb
12.6.1 Company profile
12.6.2 Representative Immuno-oncology Drugs Product
12.6.3 Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Bristol-Myers Squibb
12.7 AbbVie, Inc.
12.7.1 Company profile
12.7.2 Representative Immuno-oncology Drugs Product
12.7.3 Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of AbbVie, Inc.
12.8 Merck & Co.
12.8.1 Company profile
12.8.2 Representative Immuno-oncology Drugs Product
12.8.3 Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Merck & Co.
12.9 Eli Lilly and Company
12.9.1 Company profile
12.9.2 Representative Immuno-oncology Drugs Product
12.9.3 Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Eli Lilly and Company
12.10 Novartis International AG
12.10.1 Company profile
12.10.2 Representative Immuno-oncology Drugs Product
12.10.3 Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Novartis International AG
12.11 Prometheus Therapeutics & Diagnostics
12.11.1 Company profile
12.11.2 Representative Immuno-oncology Drugs Product
12.11.3 Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Prometheus Therapeutics & Diagnostics
12.12 Bavarian Nordic
12.12.1 Company profile
12.12.2 Representative Immuno-oncology Drugs Product
12.12.3 Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Bavarian Nordic
12.13 Pfizer Inc.
12.13.1 Company profile
12.13.2 Representative Immuno-oncology Drugs Product
12.13.3 Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Pfizer Inc.
12.14 ImmunoCellular Therapeutics
12.14.1 Company profile
12.14.2 Representative Immuno-oncology Drugs Product
12.14.3 Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of ImmunoCellular Therapeutics
12.15 Aduro BioTech
12.15.1 Company profile
12.15.2 Representative Immuno-oncology Drugs Product
12.15.3 Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Aduro BioTech
12.16 Gilead Sciences Inc.
12.17 Sanofi S.A.
12.18 Celldex Therapeutics
12.19 Galena Biopharma
12.20 EMD Serono, Inc.
12.21 Bio-Rad Laboratories, Inc.
12.22 Incyte
12.23 Lonza Group
12.24 Enzo Biochem, Inc.
12.25 Spring Bank Pharmaceuticals, Inc.
12.26 Agenus Inc.
12.27 Ferring Pharmaceuticals
12.28 Dendreon Corporation
12.29 Avantor, Inc.
12.30 Agilent Technologies Inc
Chapter 13 Upstream and Downstream Market Analysis of Immuno-oncology Drugs
13.1 Industry Chain of Immuno-oncology Drugs
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
Chapter 14 Cost and Gross Margin Analysis of Immuno-oncology Drugs
14.1 Cost Structure Analysis of Immuno-oncology Drugs
14.2 Raw Materials Cost Analysis of Immuno-oncology Drugs
14.3 Labor Cost Analysis of Immuno-oncology Drugs
14.4 Manufacturing Expenses Analysis of Immuno-oncology Drugs
Chapter 15 Report Conclusion
Chapter 16 Research Methodology and Reference
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
List of Tables
Table Advantage and Disadvantage of Immune Checkpoint Inhibitors
Table Advantage and Disadvantage of Immune System Modulators
Table Advantage and Disadvantage of Cancer Vaccines
Table Advantage and Disadvantage of Oncolytic Virus
Table Advantage and Disadvantage of Others
Table Sales Volume of Immuno-oncology Drugs by Regions 2015-2019
Table Sales Value of Immuno-oncology Drugs by Regions 2015-2019
Table Production Volume of Immuno-oncology Drugs by Regions 2015-2019
Table Global Sales Volume of Immuno-oncology Drugs by Regions 2020-2026
Table Global Sales Value of Immuno-oncology Drugs by Regions 2020-2026
Table Global Production Volume of Immuno-oncology Drugs by Regions 2020-2026
Table Sales Volume of Immuno-oncology Drugs by Types 2015-2019
Table Sales Value of Immuno-oncology Drugs by Types 2015-2019
Table Sales Volume Forecast of Immuno-oncology Drugs by Types 2020-2026
Table Sales Value Forecast of Immuno-oncology Drugs by Types 2020-2026
Table Sales Volume of Immuno-oncology Drugs by Downstream Industry 2015-2019
Table Sales Volume Forecast of Immuno-oncology Drugs by Downstream Industry 2020-2026
Table North America Immuno-oncology Drugs Sales by Countries (2015-2019)
Table North America Immuno-oncology Drugs Sales Share by Countries (2015-2019)
Table North America Immuno-oncology Drugs Revenue by Countries (2015-2019)
Table North America Immuno-oncology Drugs Revenue Market Share by Countries (2015-2019)
Table North America Immuno-oncology Drugs Sales by Type (2015-2019)
Table North America Immuno-oncology Drugs Sales Share by Type (2015-2019)
Table North America Immuno-oncology Drugs Revenue by Type (2015-2019)
Table North America Immuno-oncology Drugs Revenue Share by Type (2015-2019)
Table North America Immuno-oncology Drugs Sales by Downstream Industry (2015-2019)
Table North America Immuno-oncology Drugs Sales Share by Downstream Industry (2015-2019)
Table Europe Immuno-oncology Drugs Sales by Countries (2015-2019)
Table Europe Immuno-oncology Drugs Sales Share by Countries (2015-2019)
Table Europe Immuno-oncology Drugs Revenue by Countries (2015-2019)
Table Europe Immuno-oncology Drugs Revenue Market Share by Countries (2015-2019)
Table Europe Immuno-oncology Drugs Sales by Type (2015-2019)
Table Europe Immuno-oncology Drugs Sales Share by Type (2015-2019)
Table Europe Immuno-oncology Drugs Revenue by Type (2015-2019)
Table Europe Immuno-oncology Drugs Revenue Share by Type (2015-2019)
Table Europe Immuno-oncology Drugs Sales by Downstream Industry (2015-2019)
Table Europe Immuno-oncology Drugs Sales Share by Downstream Industry (2015-2019)
Table Asia Pacific Immuno-oncology Drugs Sales by Countries (2015-2019)
Table Asia Pacific Immuno-oncology Drugs Sales Share by Countries (2015-2019)
Table Asia Pacific Immuno-oncology Drugs Revenue by Countries (2015-2019)
Table Asia Pacific Immuno-oncology Drugs Revenue Market Share by Countries (2015-2019)
Table Asia Pacific Immuno-oncology Drugs Sales by Type (2015-2019)
Table Asia Pacific Immuno-oncology Drugs Sales Share by Type (2015-2019)
Table Asia Pacific Immuno-oncology Drugs Revenue by Type (2015-2019)
Table Asia Pacific Immuno-oncology Drugs Revenue Share by Type (2015-2019)
Table Asia Pacific Immuno-oncology Drugs Sales by Downstream Industry (2015-2019)
Table Asia Pacific Immuno-oncology Drugs Sales Share by Downstream Industry (2015-2019)
Table Latin America Immuno-oncology Drugs Sales by Countries (2015-2019)
Table Latin America Immuno-oncology Drugs Sales Share by Countries (2015-2019)
Table Latin America Immuno-oncology Drugs Revenue by Countries (2015-2019)
Table Latin America Immuno-oncology Drugs Revenue Market Share by Countries (2015-2019)
Table Latin America Immuno-oncology Drugs Sales by Type (2015-2019)
Table Latin America Immuno-oncology Drugs Sales Share by Type (2015-2019)
Table Latin America Immuno-oncology Drugs Revenue by Type (2015-2019)
Table Latin America Immuno-oncology Drugs Revenue Share by Type (2015-2019)
Table Latin America Immuno-oncology Drugs Sales by Downstream Industry (2015-2019)
Table Latin America Immuno-oncology Drugs Sales Share by Downstream Industry (2015-2019)
Table Middle East and Africa Immuno-oncology Drugs Sales by Regions (2015-2019)
Table Middle East and Africa Immuno-oncology Drugs Sales Share by Regions (2015-2019)
Table Middle East and Africa Immuno-oncology Drugs Revenue by Regions (2015-2019)
Table Middle East and Africa Immuno-oncology Drugs Revenue Market Share by Regions (2015-2019)
Table Middle East and Africa Immuno-oncology Drugs Sales by Type (2015-2019)
Table Middle East and Africa Immuno-oncology Drugs Sales Share by Type (2015-2019)
Table Middle East and Africa Immuno-oncology Drugs Revenue by Type (2015-2019)
Table Middle East and Africa Immuno-oncology Drugs Revenue Share by Type (2015-2019)
Table Middle East and Africa Immuno-oncology Drugs Sales by Downstream Industry (2015-2019)
Table Middle East and Africa Immuno-oncology Drugs Sales Share by Downstream Industry (2015-2019)
Table Production Volume of Immuno-oncology Drugs by Major Manufacturers 2015-2019
Table Production Value of Immuno-oncology Drugs by Major Manufacturers 2015-2019
Table Headquarters Location and Established Time of Immuno-oncology Drugs Major Manufacturer
Table Employees and Revenue Level of Immuno-oncology Drugs Major Manufacturer
Table Representative Immuno-oncology Drugs Product One of Amgen, Inc
Table Representative Immuno-oncology Drugs Product Two of Amgen, Inc
Table Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Amgen, Inc 2015-2019
Table Representative Immuno-oncology Drugs Product One of Johnson & Johnson
Table Representative Immuno-oncology Drugs Product Two of Johnson & Johnson
Table Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Johnson & Johnson 2015-2019
Table Representative Immuno-oncology Drugs Product One of Celgene Corporation
Table Representative Immuno-oncology Drugs Product Two of Celgene Corporation
Table Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Celgene Corporation 2015-2019
Table Representative Immuno-oncology Drugs Product One of AstraZeneca, Plc
Table Representative Immuno-oncology Drugs Product Two of AstraZeneca, Plc
Table Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of AstraZeneca, Plc 2015-2019
Table Representative Immuno-oncology Drugs Product One of Hoffmann-La Roche AG
Table Representative Immuno-oncology Drugs Product Two of Hoffmann-La Roche AG
Table Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Hoffmann-La Roche AG 2015-2019
Table Representative Immuno-oncology Drugs Product One of Bristol-Myers Squibb
Table Representative Immuno-oncology Drugs Product Two of Bristol-Myers Squibb
Table Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Bristol-Myers Squibb 2015-2019
Table Representative Immuno-oncology Drugs Product One of AbbVie, Inc.
Table Representative Immuno-oncology Drugs Product Two of AbbVie, Inc.
Table Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of AbbVie, Inc. 2015-2019
Table Representative Immuno-oncology Drugs Product One of Merck & Co.
Table Representative Immuno-oncology Drugs Product Two of Merck & Co.
Table Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Merck & Co. 2015-2019
Table Representative Immuno-oncology Drugs Product One of Eli Lilly and Company
Table Representative Immuno-oncology Drugs Product Two of Eli Lilly and Company
Table Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Eli Lilly and Company 2015-2019
Table Representative Immuno-oncology Drugs Product One of Novartis International AG
Table Representative Immuno-oncology Drugs Product Two of Novartis International AG
Table Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Novartis International AG 2015-2019
Table Representative Immuno-oncology Drugs Product One of Prometheus Therapeutics & Diagnostics
Table Representative Immuno-oncology Drugs Product Two of Prometheus Therapeutics & Diagnostics
Table Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Prometheus Therapeutics & Diagnostics 2015-2019
Table Representative Immuno-oncology Drugs Product One of Bavarian Nordic
Table Representative Immuno-oncology Drugs Product Two of Bavarian Nordic
Table Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Bavarian Nordic 2015-2019
Table Representative Immuno-oncology Drugs Product One of Pfizer Inc.
Table Representative Immuno-oncology Drugs Product Two of Pfizer Inc.
Table Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Pfizer Inc. 2015-2019
Table Representative Immuno-oncology Drugs Product One of ImmunoCellular Therapeutics
Table Representative Immuno-oncology Drugs Product Two of ImmunoCellular Therapeutics
Table Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of ImmunoCellular Therapeutics 2015-2019
Table Representative Immuno-oncology Drugs Product One of Aduro BioTech
Table Representative Immuno-oncology Drugs Product Two of Aduro BioTech
Table Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Aduro BioTech 2015-2019
List of Figures
Figure Representative Commercial Product Picture of Immuno-oncology Drugs
Figure Global Shipments Volume Share of Immuno-oncology Drugs by Types in 2019
Figure Representative Commercial Product Picture of Immune Checkpoint Inhibitors
Figure Representative Commercial Product Picture of Immune System Modulators
Figure Representative Commercial Product Picture of Cancer Vaccines
Figure Representative Commercial Product Picture of Oncolytic Virus
Figure Representative Commercial Product Picture of Others
Figure Demand Volume Share of Immuno-oncology Drugs by Downstream Industry in 2019
Figure Hospitals Examples of Immuno-oncology Drugs
Figure Clinics Examples of Immuno-oncology Drugs
Figure Ambulatory Surgical Centers Examples of Immuno-oncology Drugs
Figure Global Immuno-oncology Drugs Revenue and Growth Rate 2015-2026
Figure Global Immuno-oncology Drugs Market Size Comparison in 2015, 2019 and 2026
Figure North America Immuno-oncology Drugs Revenue and Growth Rate 2015-2026
Figure Europe Immuno-oncology Drugs Revenue and Growth Rate 2015-2026
Figure Asia Pacific Immuno-oncology Drugs Revenue and Growth Rate 2015-2026
Figure Latin America Immuno-oncology Drugs Revenue and Growth Rate 2015-2026
Figure Middle East and Africa Immuno-oncology Drugs Revenue and Growth Rate 2015-2026
Figure Latin America Immuno-oncology Drugs Revenue and Growth Rate 2015-2026
Figure Global Sales Volume and Growth Rate of Immuno-oncology Drugs 2015-2019
Figure Global Sales Value and Growth Rate of Immuno-oncology Drugs 2015-2019
Figure Sales Volume Share of Immuno-oncology Drugs by Regions 2015-2019
Figure Sales Volume Share of Immuno-oncology Drugs by Regions in 2015
Figure Sales Volume Share of Immuno-oncology Drugs by Regions in 2019
Figure Sales Volume Growth Rate Comparison of Immuno-oncology Drugs by Regions 2015-2019
Figure Sales Value Share of Immuno-oncology Drugs by Regions 2015-2019
Figure Sales Value Share of Immuno-oncology Drugs by Regions in 2015
Figure Sales Value Share of Immuno-oncology Drugs by Regions in 2019
Figure Sales Value Growth Rate Comparison of Immuno-oncology Drugs by Regions 2015-2019
Figure Production Volume Share of Immuno-oncology Drugs by Regions 2015-2019
Figure Production Volume Share of Immuno-oncology Drugs by Regions in 2015
Figure Production Volume Share of Immuno-oncology Drugs by Regions in 2019
Figure Global Sales Volume and Growth Rate of Immuno-oncology Drugs 2020-2026
Figure Global Revenue and Growth Rate of Immuno-oncology Drugs 2020-2026
Figure Global Sales Volume Share of Immuno-oncology Drugs by Regions in 2026
Figure Global Sales Value Share of Immuno-oncology Drugs by Regions in 2026
Figure Global Production Volume Share of Immuno-oncology Drugs by Regions in 2026
Figure Sales Volume Share of Immuno-oncology Drugs by Types 2015-2019
Figure Sales Volume Share of Immuno-oncology Drugs by Types in 2015
Figure Sales Volume Share of Immuno-oncology Drugs by Types in 2019
Figure Sales Volume Growth Rate Comparison of Immuno-oncology Drugs by Types 2015-2019
Figure Sales Value Share of Immuno-oncology Drugs by Types 2015-2019
Figure Sales Value Share of Immuno-oncology Drugs by Types in 2015
Figure Sales Value Share of Immuno-oncology Drugs by Types in 2019
Figure Sales Value Growth Rate Comparison of Immuno-oncology Drugs by Types 2015-2019
Figure Sales Volume Share Forecast of Immuno-oncology Drugs by Types in 2026
Figure Sales Value Share Forecast of Immuno-oncology Drugs by Types in 2026
Figure Sales Volume Share of Immuno-oncology Drugs by Downstream Industry 2015-2019
Figure Sales Volume Share of Immuno-oncology Drugs by Downstream Industry in 2015
Figure Sales Volume Share of Immuno-oncology Drugs by Downstream Industry in 2019
Figure Sales Volume Growth Rate Comparison of Immuno-oncology Drugs by Downstream Industry 2015-2019
Figure Sales Volume Share Forecast of Immuno-oncology Drugs by Downstream Industry in 2026
Figure North America Immuno-oncology Drugs Sales Share by Countries in 2015
Figure North America Immuno-oncology Drugs Sales Share by Countries in 2019
Figure North America Immuno-oncology Drugs Revenue Market Share by Countries in 2015
Figure North America Immuno-oncology Drugs Revenue Market Share by Countries in 2019
Figure United States Immuno-oncology Drugs Sales and Growth Rate (2015-2019)
Figure United States Immuno-oncology Drugs Revenue and Growth Rate (2015-2019)
Figure Canada Immuno-oncology Drugs Sales and Growth Rate (2015-2019)
Figure Canada Immuno-oncology Drugs Revenue and Growth Rate (2015-2019)
Figure Mexico Immuno-oncology Drugs Sales and Growth Rate (2015-2019)
Figure Mexico Immuno-oncology Drugs Revenue and Growth Rate (2015-2019)
Figure North America Immuno-oncology Drugs Sales Market Share by Manufacturer in 2019
Figure Europe Immuno-oncology Drugs Sales Share by Countries in 2015
Figure Europe Immuno-oncology Drugs Sales Share by Countries in 2019
Figure Europe Immuno-oncology Drugs Revenue Market Share by Countries in 2015
Figure Europe Immuno-oncology Drugs Revenue Market Share by Countries in 2019
Figure Germany Immuno-oncology Drugs Sales and Growth Rate (2015-2019)
Figure Germany Immuno-oncology Drugs Revenue and Growth Rate (2015-2019)
Figure UK Immuno-oncology Drugs Sales and Growth Rate (2015-2019)
Figure UK Immuno-oncology Drugs Revenue and Growth Rate (2015-2019)
Figure France Immuno-oncology Drugs Sales and Growth Rate (2015-2019)
Figure France Immuno-oncology Drugs Revenue and Growth Rate (2015-2019)
Figure Italy Immuno-oncology Drugs Sales and Growth Rate (2015-2019)
Figure Italy Immuno-oncology Drugs Revenue and Growth Rate (2015-2019)
Figure Russia Immuno-oncology Drugs Sales and Growth Rate (2015-2019)
Figure Russia Immuno-oncology Drugs Revenue and Growth Rate (2015-2019)
Figure Spain Immuno-oncology Drugs Sales and Growth Rate (2015-2019)
Figure Spain Immuno-oncology Drugs Revenue and Growth Rate (2015-2019)
Figure Benelux Immuno-oncology Drugs Sales and Growth Rate (2015-2019)
Figure Benelux Immuno-oncology Drugs Revenue and Growth Rate (2015-2019)
Figure Europe Immuno-oncology Drugs Sales Market Share by Manufacturer in 2019
Figure Asia Pacific Immuno-oncology Drugs Sales Share by Countries in 2015
Figure Asia Pacific Immuno-oncology Drugs Sales Share by Countries in 2019
Figure Asia Pacific Immuno-oncology Drugs Revenue Market Share by Countries in 2015
Figure Asia Pacific Immuno-oncology Drugs Revenue Market Share by Countries in 2019
Figure China Immuno-oncology Drugs Sales and Growth Rate (2015-2019)
Figure China Immuno-oncology Drugs Revenue and Growth Rate (2015-2019)
Figure Japan Immuno-oncology Drugs Sales and Growth Rate (2015-2019)
Figure Japan Immuno-oncology Drugs Revenue and Growth Rate (2015-2019)
Figure India Immuno-oncology Drugs Sales and Growth Rate (2015-2019)
Figure India Immuno-oncology Drugs Revenue and Growth Rate (2015-2019)
Figure Southeast Asia Immuno-oncology Drugs Sales and Growth Rate (2015-2019)
Figure Southeast Asia Immuno-oncology Drugs Revenue and Growth Rate (2015-2019)
Figure Australia Immuno-oncology Drugs Sales and Growth Rate (2015-2019)
Figure Australia Immuno-oncology Drugs Revenue and Growth Rate (2015-2019)
Figure Asia Pacific Immuno-oncology Drugs Sales Market Share by Manufacturer in 2019
Figure Latin America Immuno-oncology Drugs Sales Share by Countries in 2015
Figure Latin America Immuno-oncology Drugs Sales Share by Countries in 2019
Figure Latin America Immuno-oncology Drugs Revenue Market Share by Countries in 2015
Figure Latin America Immuno-oncology Drugs Revenue Market Share by Countries in 2019
Figure Brazil Immuno-oncology Drugs Sales and Growth Rate (2015-2019)
Figure Brazil Immuno-oncology Drugs Revenue and Growth Rate (2015-2019)
Figure Argentina Immuno-oncology Drugs Sales and Growth Rate (2015-2019)
Figure Argentina Immuno-oncology Drugs Revenue and Growth Rate (2015-2019)
Figure Colombia Immuno-oncology Drugs Sales and Growth Rate (2015-2019)
Figure Colombia Immuno-oncology Drugs Revenue and Growth Rate (2015-2019)
Figure Latin America Immuno-oncology Drugs Sales Market Share by Manufacturer in 2019
Figure Middle East and Africa Immuno-oncology Drugs Sales Share by Regions in 2015
Figure Middle East and Africa Immuno-oncology Drugs Sales Share by Regions in 2019
Figure Middle East and Africa Immuno-oncology Drugs Revenue Market Share by Regions in 2015
Figure Middle East and Africa Immuno-oncology Drugs Revenue Market Share by Regions in 2019
Figure Middle East Immuno-oncology Drugs Sales and Growth Rate (2015-2019)
Figure Middle East Immuno-oncology Drugs Revenue and Growth Rate (2015-2019)
Figure Africa Immuno-oncology Drugs Sales and Growth Rate (2015-2019)
Figure Africa Immuno-oncology Drugs Revenue and Growth Rate (2015-2019)
Figure Middle East and Africa Immuno-oncology Drugs Sales Market Share by Manufacturer in 2019
Figure Production Volume Share of Immuno-oncology Drugs by Major Manufacturers in 2015
Figure Production Volume Share of Immuno-oncology Drugs by Major Manufacturers in 2019
Figure Production Value Share of Immuno-oncology Drugs by Major Manufacturers in 2015
Figure Production Value Share of Immuno-oncology Drugs by Major Manufacturers in 2019
Figure Immuno-oncology Drugs Revenue and Market Share of Amgen, Inc 2015-2019
Figure Immuno-oncology Drugs Revenue and Market Share of Johnson & Johnson 2015-2019
Figure Immuno-oncology Drugs Revenue and Market Share of Celgene Corporation 2015-2019
Figure Immuno-oncology Drugs Revenue and Market Share of AstraZeneca, Plc 2015-2019
Figure Immuno-oncology Drugs Revenue and Market Share of Hoffmann-La Roche AG 2015-2019
Figure Immuno-oncology Drugs Revenue and Market Share of Bristol-Myers Squibb 2015-2019
Figure Immuno-oncology Drugs Revenue and Market Share of AbbVie, Inc. 2015-2019
Figure Immuno-oncology Drugs Revenue and Market Share of Merck & Co. 2015-2019
Figure Immuno-oncology Drugs Revenue and Market Share of Eli Lilly and Company 2015-2019
Figure Immuno-oncology Drugs Revenue and Market Share of Novartis International AG 2015-2019
Figure Immuno-oncology Drugs Revenue and Market Share of Prometheus Therapeutics & Diagnostics 2015-2019
Figure Immuno-oncology Drugs Revenue and Market Share of Bavarian Nordic 2015-2019
Figure Immuno-oncology Drugs Revenue and Market Share of Pfizer Inc. 2015-2019
Figure Immuno-oncology Drugs Revenue and Market Share of ImmunoCellular Therapeutics 2015-2019
Buy
